Xeris Biopharma Holdings, Inc. (XERS)

NASDAQ: XERS · IEX Real-Time Price · USD

2.365

-0.015 (-0.63%)

At close: Jul 19, 2024, 4:00 PM

2.350

-0.015 (-0.63%)

Pre-market: Jul 20, 2024, 9:28 AM EDT

Xeris Biopharma Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2016
Net Income	-64.4	-62.26	-94.66	-122.73	-91.14	-125.58	Upgrade
Depreciation & Amortization	13.19	13.16	12.67	1.88	1.47	1.08	Upgrade
Share-Based Compensation	11.92	10.72	12.16	11.38	8.27	6.48	Upgrade
Other Operating Activities	-1.9	-8.64	-33.06	13.93	0.84	13.67	Upgrade
Operating Cash Flow	-41.19	-47.02	-102.89	-95.54	-80.56	-104.35	Upgrade
Capital Expenditures	-2.19	-2.26	-0.52	-1.09	-0.38	-1.11	Upgrade
Acquisitions	0	0	0	38.47	0	0	Upgrade
Change in Investments	20.51	-3.74	34.99	60.58	-27.03	-1.28	Upgrade
Investing Cash Flow	18.33	-6	34.46	97.96	-27.41	-2.38	Upgrade
Share Issuance / Repurchase	-2.54	-0.43	30.37	27.25	62.32	57.91	Upgrade
Debt Issued / Paid	36.98	-1.19	97.11	0	63.75	22.62	Upgrade
Financing Cash Flow	34.44	-1.61	127.47	27.25	126.06	80.53	Upgrade
Exchange Rate Effect	0	0	0	-0	-0.02	0	Upgrade
Net Cash Flow	11.58	-54.64	59.04	29.67	18.08	-26.2	Upgrade
Free Cash Flow	-43.38	-49.29	-103.42	-96.62	-80.94	-105.45	Upgrade
Free Cash Flow Margin	-25.31%	-30.07%	-93.80%	-194.84%	-396.06%	-3874.10%	Upgrade
Free Cash Flow Per Share	-0.31	-0.36	-0.76	-1.22	-1.90	-4.04	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).